<DOC>
	<DOC>NCT02035189</DOC>
	<brief_summary>An observational study in evaluating the clinical impact of procalcitonin on the care of Stem cell transplant recipient and its performance as an adjunct in the diagnosis and prognostication of Infectious processes</brief_summary>
	<brief_title>Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients</brief_title>
	<detailed_description>The overall goal of this project will be to provide new insights into the use of biomarkers in surveillance for infectious processes in Stem Cell Transplant recipients by evaluating the added impact of procalcitonin testing on detection of infectious processes</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<criteria>Patients age 1895 years with Multiple Myeloma (MM) undergoing stem cell transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>